A new report suggests that millions of U.S. adults are unaware they may have undiagnosed cardiovascular risk factors that ...

Germany: Researchers have found that the salivary free aldosterone awakening response (AldAR) differs significantly among men with coronary heart disease (CHD), essential hypertension, and ...

Journal of Nuclear Medicine January 2026, jnumed.125.271006; DOI: https://doi.org/10.2967/jnumed.125.271006 ...

Salivary free aldosterone awakening response (AldAR) differed in men with coronary heart disease and essential hypertension compared with healthy control individuals with normotension. Higher AldAR ...

The start-up Function will send practically anyone to a lab for extensive medical testing, no physical required. Is that a good thing? By Kristen V. Brown As Kimberly Crisp approached middle age, ...

O'Brien and co-authors provide important data demonstrating that tissue-resident macrophages can exert physiological functions and influence endocrine systems.Their model in which AMs negatively ...

The Global Aldosterone Synthase Inhibitors Market is estimated to be valued at USD 225.9 Mn in 2025 and is expected to reach USD 369.6 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of ...

Raised blood pressure remains the leading modifiable risk factor for cardiovascular disease and premature mortality worldwide, affecting an estimated 1·3 billion adults.1 Although most patients ...

Lorundrostat, a novel therapy which blocks the production of aldosterone from the adrenal glands, demonstrated clinically meaningful and sustained reductions in blood pressure in 1,083 patients with ...

Therefore, we considered it of interest to test the hypothesis that the aldosterone antagonist canrenone can improve LV diastolic function in patients with essential hypertension. We planned a ...